IRIS
FURFARO, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.546
AS - Asia 178
SA - Sud America 16
NA - Nord America 7
AF - Africa 3
Totale 3.750
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 3.543
SG - Singapore 73
CN - Cina 48
VN - Vietnam 46
BR - Brasile 7
US - Stati Uniti d'America 5
AR - Argentina 4
EC - Ecuador 4
BD - Bangladesh 3
HK - Hong Kong 3
DZ - Algeria 2
GB - Regno Unito 2
MX - Messico 2
BY - Bielorussia 1
CO - Colombia 1
ID - Indonesia 1
KG - Kirghizistan 1
NP - Nepal 1
PK - Pakistan 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 3.750
Salva come PNG Salva come JPEG
Città #
Genova 2.142
Genoa 846
Rapallo 308
Vado Ligure 237
Singapore 21
Beijing 19
Ho Chi Minh City 18
Hanoi 11
Bordighera 6
Hong Kong 3
Ashburn 2
Biên Hòa 2
Bắc Giang 2
Catania 2
Da Nang 2
Mexico City 2
Poplar 2
Thái Nguyên 2
Algiers 1
Ambato 1
Antakya 1
Apuí Municipality 1
Atlanta 1
Bishkek 1
Brooklyn 1
Buenos Aires 1
Cape Town 1
Concordia 1
Guayaquil 1
Haiphong 1
Itacaré 1
Jaú 1
Lahore 1
Minsk 1
Montelíbano 1
New York 1
Ninh Bình 1
Oran 1
Palermo 1
Porto Alegre 1
Presidencia Roque Sáenz Peña 1
Quito 1
Quảng Ngãi 1
Rangpur City 1
Sumaré 1
Surabaya 1
Tulcán 1
Viamão 1
Vũng Tàu 1
Água Azul do Norte 1
Totale 3.659
Salva come PNG Salva come JPEG
Nome #
Initial serum (1,3)-β-d-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil 206
Pharmacokinetics of Lopinavir Determined with an ELISA Test in Youths with Perinatally Acquired HIV. 164
Non-cultural methods for the diagnosis of invasive fungal disease 162
Biomarkers for Diagnosis and Follow-Up of Invasive Candidiasis: A Brief Review of the ECIL Recommendations 159
Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia? Authors' response 159
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies 156
Galactomannan in piperacillin-tazobactam: how much and to what extent? 154
Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia 153
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis 149
Invasive mycoses in children receiving hemopoietic SCT 148
(1-3)-β-d-glucan in cerebrospinal fluid is useful for the diagnosis of central nervous system fungal infections. 148
Galactomannan: testing the same sample twice? 143
High levels of beta-D-glucan in immunocompromised children with proven invasive fungal disease 141
Piperacillin/tazobactam (TazocinTM) seems to be no longer responsible forfalse-positive results of the galactomannan assay 136
The Beta-d-glucan Test: Time to Re-Visit Its Utility in IFI Diagnosis 132
Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections. 132
Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 130
Galactomannan testing might be useful for early diagnosis of fusariosis. 129
Screening With Serum Galactomannan Might Be Associated With Better Outcome Than Symptom-Triggered Galactomannan Testing in Allogeneic HSCT Recipients With Invasive Aspergillosis. 128
Performance of 1,3-β-D-glucan for diagnosing invasive fungal diseases in children 128
Aspergillus meningitis: A rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases. 124
Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation 123
Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy 103
Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients 97
Case report of the reliability 1,3-β-D-glucan monitoring during treatment of peritoneal candidiasis in a child receiving continuous peritoneal dialysis 96
Persistence of a positive (1,3)-beta-D-glucan test after clearance of candidemia in hematopoietic stem cell transplant recipients. 90
Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan 89
Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study 60
Bloodstream infections are an improbable cause of positive serum (1,3)-β-D-glucan in hematology patients 55
The Importance of Quantitative Results of a Lateral Flow Aspergillus Assay: The Significant Impact on Specificity 10
Totale 3.804
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.684
article - articoli 12.684
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.368
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021186 0 0 0 0 0 20 15 62 17 37 14 21
2021/2022343 6 16 16 48 18 45 17 74 15 38 8 42
2022/2023369 35 38 7 35 64 65 1 25 56 4 28 11
2023/2024192 10 21 4 30 18 32 11 8 9 2 23 24
2024/2025582 6 38 12 37 92 60 46 100 17 23 56 95
2025/2026467 151 20 49 71 157 19 0 0 0 0 0 0
Totale 3.804